Hong Kong stocks fluctuate | Beihai Kangcheng-B (01228.HK) rises more than 12% again, company receives strategic investment from Baiyang Medicine, three products under the company pass the initial review of the national innovative drug catalog.

According to the Zhitong Finance and Economics APP, Beihai Kangcheng-B (01228.HK) has increased by over 12% again, with a cumulative increase of nearly 20 times this year. As of the time of publication, it has risen by 11.69%, reaching 2.77 Hong Kong dollars, with a trading volume of 50.0784 million Hong Kong dollars.